BDNF is widely regarded as a significant biomarker in the realm of cognitive impairment, with numerous studies consistently demonstrating diminished BDNF levels in patients exhibiting cognitive deficits associated with mild cognitive impairment (MCI). The gene discussed is BDNF; the disease is Cognitive impairment.